SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating PTC Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

Published: Aug. 18, 2022 at 8:30 AM EDT

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PTC Therapeutics, Inc. (NASDAQ: PTCT).

If you are a shareholder of PTC Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:

You may also contact Robert H. Lefkowitz, Esq. either via email at or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit Attorney advertising. Prior results do not guarantee a similar outcome.

View original content:

SOURCE Purcell & Lefkowitz LLP

The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.